All articles by Sarah Houlton – Page 3
-
BusinessEurope opens gates to CAR-T
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
-
BusinessGene therapy gathers pace
Sarah Houlton charts the evolution, challenges and opportunities of cell and gene therapy
-
BusinessRural power champion
Clementine Chambon is the 2018 Chemistry World Entrepreneur of the Year for her work using bioenergy to solve environmental, social and gender challenges in rural India
-
BusinessDeal protects world’s biggest selling drug from biosimilar erosion
AbbVie and Samsung Bioepis resolve patent litigation over arthritis drug Humira
-
BusinessAkzoNobel sells off specialty chemicals arm in €10bn deal
Private equity firm Carlyle sees off several other bidders
-
BusinessFit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
-
FeatureCarolyn Bertozzi
One-time heavy rocker Carolyn Bertozzi has made a name for herself with hit papers and sound science. Sarah Houlton charts her path to success
-
BusinessPharmaceuticals roundup 2017
Political influence has strongly shaped industry activity in the past year
-
BusinessSanofi ordered to pull dengue vaccine
Philippines wants French drugmaker to cover immunisation program costs
-
NewsLiquid cats triumph at Ig Nobels
Papers on cats, vampire bats, digeridoos and cheese disgust all won at science’s most irreverent ceremony
-
ArticleIn-house training speeds up metabolism
Business plugs DMPK skills gap to improve drug discovery
-
CareersMr Wizard’s heir
YouTube and Ellen star Steve Spangler shares how to make it big in sci-comm
-
BusinessAmplifying intelligent drug design
This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK
-
BusinessFDA asks Endo to take pain drug off market
Request part of larger strategy to address opioid misuse in the US
-
ArticleSygnature Discovery
Sygnature Discovery is part of an innovative partnership to bolster the life science sector in Nottingham
-
FeatureAccess to drugs: a failure of pharma?
Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates
-
BusinessHuntsman and Clariant agree merger deal
Uniting Huntsman’s bulk materials with Clariant’s additives gives a more integrated speciality chemicals offering
-
BusinessOnline tool tracks bio-based materials
E-certificates automatically trace ingredients through supply chain processes
-
BusinessLilly loses arbitration over Canadian patents
Firm had sought recompense under the Nafta trade agreement
-
BusinessCrispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other